Big Pharma - Is There Something Sinister Behind the Production Reduction at Phizer? At the Very Least, Phizer is Not for Octogenarians

..

UK, EU, Canada to face delay in delivery of Pfizer vaccine

In a letter to the EU commission health and social affairs ministers of six states

called the situation ‘unacceptable’

Nadeem Badshah and agency

Sat 16 Jan 2021 00.04 GMT

Pfizer is upscaling production at its plant in Puurs, Belgium, in efforts to produce more doses for 2021,

temporarily reducing deliveries to all European countries. Photograph: Olivier Hoslet/EPA

The UK is among several countries facing delays in delivery of the Pfizer/BioNTech coronavirus vaccine due to upgrades in its production capacity, the company has said.

The US pharmaceutical firm is increasing production at its plant in Puurs, Belgium, in an effort to produce more doses than originally planned for 2021, temporarily reducing deliveries to all European countries.

Shipments of the vaccine, produced in partnership with Germany’s BioNTech, to the UK are set to be affected this month.

The UK has secured 40 million doses of the Pfizer/BioNTech vaccine.

A government spokesperson said: “We are in the process of understanding the implications of Pfizer’s announcement today to our plans. However, we continue to plan to hit our target of vaccinating all four priority groups by 15 February.”

The Oxford/AstraZeneca jab is also licensed and being used in the UK. 

However, the Oxford/Astra Zeneca vaccine is only about 62% effective while Pfizer and Moderna are more than 90% effective.

European governments have said the credibility of their vaccination programmes are at risk due to Pfizer’s decision. “This situation is unacceptable,” the health and social affairs ministers of six EU states – Sweden, Denmark, Finland, Lithuania, Latvia and Estonia – said in a letter to the EU commission. Not only does it impact the planned vaccination schedules, it also decreases the credibility of the vaccination process.”

Germany, Europe’s largest purchaser of the vaccine, said that it regretted the “unexpected and … very short notice” announcement as the company had promised “binding delivery dates” until the middle of next month.

Norway and Lithuania had earlier said that the pharmaceutical company was reducing supplies across Europe.

See article immediately below...

“What we want is for Pfizer-BioNTech to restore their deliveries to the agreed schedule,” Lithuanian health minister Arunas Dulkys told Reuters.

A Pfizer spokesperson said: “We understand a change to deliveries has the potential to create uncertainty. However, we can confirm the overall projected volumes of delivery to the UK remain the same for quarter one (January to March).

“We continue to liaise with the UK Government and the Vaccines Taskforce to work through short-term impact of these changes to our January deliveries and support the goals of the UK Covid-19 vaccination programme.”

Boris Johnson said on Friday that the UK has vaccinated more than 3.2 million, with almost 45% of over-80s and 40% of care home residents receiving doses so far.

At least 23 die after receiving COVID-19 vaccine in Norway

BY ANADOLU AGENCY

 ANKARA EUROPE JAN 15, 2021 1:09 PM GMT+3

A man receives a COVID-19 vaccine at Englewood Health in Englewood, New Jersey, U.S., Jan. 14, 2021. (AP Photo)

At least 23 people who received the COVID-19 vaccine developed by U.S. firm Pfizer and Germany's BioNTech have died in Norway, with 13 of the fatalities linked to the vaccine's side effects, authorities said Thursday.

All 13 individuals were above the age of 80, according to the Norwegian Medicines Agency.

It noted that the Pfizer-BioNTech vaccine's common side effects, such as fever and nausea, could have contributed to the death of some elderly recipients of the shot.

Along with the 13 deaths, nine cases of serious side effects and seven instances of less serious side effects have been recorded, the agency's medical director, Steinar Madsen, told national broadcaster NRK.

Norway launched its vaccination campaign last month, right after the Pfizer-BioNTech vaccine was approved by the European Medicines Agency (EMA).

Nearly 33,000 people have received a dose in the country, according to data by U.K.-based tracker OurWorldInData.

The latest figures show Norway's virus caseload currently stands at 57,736, including 511 fatalities.

So, Norway has decided the Pfizer vaccine should not be given to anyone over 80. When will we hear the same recommendation from Pfizer? Is that what the stalling is about? Are they making sure that deaths from the vaccine are at an 'acceptable level'!

Companies this big don't suddenly do anything unless something completely unexpected and potentially injurious to the company's bottom-line occurred. 

Why are countries not studying Ivermectin's effectiveness? It is the only possibly effective drug that has already passed through rigorous testing, rather than the experimental vaccines that will make Big Pharma stupid rich and have God-knows-what effect on people.

One effect for sure is it will make people poorer as countries spend billions of dollars on experimental vaccines. 

It was reported just this morning that 13 people in Israel developed facial paralysis after taking Pfizer's vaccine.